Ignite Creation Date:
2024-05-06 @ 8:20 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06340568
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-29
First Post:
2024-03-25
Brief Title:
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients with Recurring Uterine Cancer
Sponsor:
BioNTech SE
Organization:
BioNTech SE
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Endometrial Cancer |
Keywords:
| Name | View |
|---|---|
| Antibody drug conjugate | View |
| Human epidermal growth factor receptor 2 HER2 | View |
| HER2-expressing tumors | View |
| Recurrent endometrial cancer | View |
| IHC scores 1 2 and 3 | View |
| Immune checkpoint inhibitor | View |
| Platinum-based therapy | View |
| HER2 protein expression | View |
| HER2-expressing endometrial cancer | View |
| ErbB-2 receptor | View |